Related content

The effect of weight loss on anti-Mllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment

By Thomson R.L.   Buckley J.D.   Moran L.J.   Noakes M.   Clifton P.M.   Norman R.J.   Brinkworth G.D.  

Human Reproduction, Vol. 24, Iss. 8, 2009-08 ,pp. : 1976-1981

Oxford University Press

Access to resources Recommend Favorite

Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet

By Carmina Enrico  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2289-2293

Oxford University Press

Access to resources Recommend Favorite

Obesity, body composition and metabolic disturbances in polycystic ovary syndrome

By Svendsen Pernille Fog   Nilas Lisbeth   Nrgaard Kirsten   Jensen Jens-Erik Beck   Madsbad Sten  

Human Reproduction, Vol. 23, Iss. 9, 2008-09 ,pp. : 2113-2121

Oxford University Press

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Body fat composition and distribution in women with polycystic ovary syndrome

By Cosar Emine   Ucok Kağan   Akgun Lutfi   Koken Gulengul   Sahin Figen Kir   Arioz Dagistan Tolga   Bas Orhan  

Gynecological Endocrinology, Vol. 24, Iss. 8, 2008-01 ,pp. : 428-432

Informa Healthcare

Access to resources Recommend Favorite